HRTX logo

Heron Therapeutics (HRTX) Long Term Liabilities

Annual Total Long Term Liabilities

$176.79 M
+$21.77 M+14.04%

31 December 2023

HRTX Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$175.24 M
-$521.00 K-0.30%

30 September 2024

HRTX Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HRTX Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.0%-1.1%
3 y3 years+1114.2%+8.7%
5 y5 years+100.0%+1525.1%

HRTX Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1114.2%-1.1%+13.9%
5 y5 yearsat high-1.1%+1525.1%
alltimeall timeat high-1.1%

Heron Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$175.24 M(-0.3%)
June 2024
-
$175.76 M(-0.3%)
Mar 2024
-
$176.28 M(-0.3%)
Dec 2023
$176.79 M(+14.0%)
$176.79 M(-0.3%)
Sept 2023
-
$177.24 M(+15.3%)
June 2023
-
$153.79 M(-0.4%)
Mar 2023
-
$154.41 M(-0.4%)
Dec 2022
$155.02 M(-1.3%)
$155.02 M(-0.4%)
Sept 2022
-
$155.63 M(-0.4%)
June 2022
-
$156.20 M(-0.4%)
Mar 2022
-
$156.76 M(-0.2%)
Dec 2021
$157.08 M(+978.8%)
$157.08 M(-2.6%)
Sept 2021
-
$161.25 M(-0.5%)
June 2021
-
$162.00 M(+1074.7%)
Mar 2021
-
$13.79 M(-5.3%)
Dec 2020
$14.56 M(+18.9%)
$14.56 M(-4.8%)
Sept 2020
-
$15.30 M(-4.5%)
June 2020
-
$16.01 M(-4.2%)
Mar 2020
-
$16.71 M(+36.5%)
Dec 2019
$12.24 M(>+9900.0%)
$12.24 M(+13.5%)
Sept 2019
-
$10.78 M(-4.2%)
June 2019
-
$11.25 M(-4.0%)
Mar 2019
-
$11.72 M(>+9900.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sept 2018
-
$0.00(0.0%)
June 2018
-
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
Dec 2017
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2017
-
$25.00 M(0.0%)
June 2017
-
$25.00 M(-50.0%)
Mar 2017
-
$50.00 M(0.0%)
Dec 2016
$50.00 M(>+9900.0%)
$50.00 M(0.0%)
Sept 2016
-
$50.00 M(>+9900.0%)
June 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sept 2015
-
$0.00(0.0%)
June 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sept 2014
-
$0.00(0.0%)
June 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sept 2013
-
$0.00(0.0%)
June 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
Sept 2012
-
$0.00(0.0%)
June 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2011
-
$64.00 K(+156.0%)
June 2011
-
$25.00 K(-43.2%)
Mar 2011
-
$44.00 K(+25.7%)
Dec 2010
$35.00 K(-86.9%)
$35.00 K(-81.5%)
Sept 2010
-
$189.00 K(-3.6%)
June 2010
-
$196.00 K(-14.0%)
Mar 2010
-
$228.00 K(-14.9%)
Dec 2009
$268.00 K(-73.6%)
$268.00 K(+77.5%)
Sept 2009
-
$151.00 K(-84.9%)
June 2009
-
$1.00 M(0.0%)
Mar 2009
-
$1.00 M(-1.5%)
Dec 2008
$1.01 M
$1.01 M(-5.3%)
Sept 2008
-
$1.07 M(-5.2%)
DateAnnualQuarterly
June 2008
-
$1.13 M(-7.1%)
Mar 2008
-
$1.22 M(-4.0%)
Dec 2007
$1.27 M(+26.9%)
$1.27 M(+26.9%)
Sept 2007
-
$1.00 M(0.0%)
June 2007
-
$1.00 M(0.0%)
Mar 2007
-
$1.00 M(0.0%)
Dec 2006
$1.00 M(+189.9%)
$1.00 M(+1233.3%)
Sept 2003
-
$75.00 K(-48.3%)
June 2003
-
$145.00 K(0.0%)
Mar 2003
-
$145.00 K(-58.0%)
Dec 2002
$345.00 K(-56.1%)
$345.00 K(-54.7%)
Sept 2002
-
$761.00 K(-8.9%)
June 2002
-
$835.00 K(+6.3%)
Mar 2002
-
$785.30 K(+0.0%)
Dec 2001
$785.00 K(-10.2%)
$785.00 K(-7.6%)
Sept 2001
-
$849.30 K(+16.0%)
June 2001
-
$732.10 K(-14.6%)
Mar 2001
-
$857.10 K(-1.9%)
Dec 2000
$874.00 K(-74.9%)
$874.00 K(-6.6%)
Sept 2000
-
$935.60 K(-65.9%)
June 2000
-
$2.74 M(-55.9%)
Mar 2000
-
$6.22 M(+78.3%)
Dec 1999
$3.49 M(-41.9%)
$3.49 M(-58.5%)
Sept 1999
-
$8.40 M(+115.4%)
June 1999
-
$3.90 M(-7.1%)
Mar 1999
-
$4.20 M(-30.0%)
Dec 1998
$6.00 M(+22.4%)
$6.00 M(+300.0%)
Sept 1998
-
$1.50 M(+1400.0%)
June 1998
-
$100.00 K(-75.0%)
Mar 1998
-
$400.00 K(-91.8%)
Dec 1997
$4.90 M(-10.9%)
$4.90 M(+32.4%)
Sept 1997
-
$3.70 M(-14.0%)
June 1997
-
$4.30 M(-14.0%)
Mar 1997
-
$5.00 M(-9.1%)
Dec 1996
$5.50 M(-14.1%)
$5.50 M(-11.3%)
Sept 1996
-
$6.20 M(+3.3%)
June 1996
-
$6.00 M(-3.2%)
Mar 1996
-
$6.20 M(-3.1%)
Dec 1995
$6.40 M(+540.0%)
$6.40 M(+18.5%)
Sept 1995
-
$5.40 M(+671.4%)
June 1995
-
$700.00 K(-30.0%)
Mar 1995
-
$1.00 M(0.0%)
Dec 1994
$1.00 M(-70.6%)
$1.00 M(-67.7%)
Sept 1994
-
$3.10 M(-3.1%)
June 1994
-
$3.20 M(-3.0%)
Mar 1994
-
$3.30 M(-2.9%)
Dec 1993
$3.40 M(-8.1%)
$3.40 M(-2.9%)
Sept 1993
-
$3.50 M(-2.8%)
June 1993
-
$3.60 M(0.0%)
Mar 1993
-
$3.60 M(-2.7%)
Dec 1992
$3.70 M(-7.5%)
$3.70 M(-7.5%)
Sept 1992
-
$4.00 M(0.0%)
June 1992
-
$4.00 M(0.0%)
Mar 1992
-
$4.00 M(0.0%)
Dec 1991
$4.00 M(+33.3%)
$4.00 M(+33.3%)
Sept 1991
-
$3.00 M(0.0%)
June 1991
-
$3.00 M(+3.4%)
Mar 1991
-
$2.90 M(-3.3%)
Dec 1990
$3.00 M(0.0%)
$3.00 M(+2900.0%)
June 1990
-
$100.00 K(-96.8%)
Mar 1990
-
$3.10 M(+3.3%)
Dec 1989
$3.00 M(+3.4%)
$3.00 M(0.0%)
Sept 1989
-
$3.00 M(0.0%)
June 1989
-
$3.00 M(+3.4%)
Dec 1988
$2.90 M(-6.5%)
$2.90 M(-6.5%)
Dec 1987
$3.10 M
$3.10 M

FAQ

  • What is Heron Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Heron Therapeutics?
  • What is Heron Therapeutics annual total long term liabilities year-on-year change?
  • What is Heron Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Heron Therapeutics?
  • What is Heron Therapeutics quarterly long term liabilities year-on-year change?

What is Heron Therapeutics annual total long term liabilities?

The current annual total long term liabilities of HRTX is $176.79 M

What is the all time high annual total long term liabilities for Heron Therapeutics?

Heron Therapeutics all-time high annual total long term liabilities is $176.79 M

What is Heron Therapeutics annual total long term liabilities year-on-year change?

Over the past year, HRTX annual total long term liabilities has changed by +$21.77 M (+14.04%)

What is Heron Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of HRTX is $175.24 M

What is the all time high quarterly long term liabilities for Heron Therapeutics?

Heron Therapeutics all-time high quarterly total long term liabilities is $177.24 M

What is Heron Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, HRTX quarterly total long term liabilities has changed by -$2.00 M (-1.13%)